BioCryst to Present at Upcoming Investor Conference

BioCryst (Nasdaq: BCRX) will present at the T.D.

Rhea-AI Summary

BioCryst (Nasdaq: BCRX) will present at the T.D. Cowen 46th Annual Health Care Conference in Boston on Tuesday, March 3, 2026 at 9:10 a.m. ET.

According to the company, a live audio webcast and replay will be available in the Investors & Media section of BioCryst's website at www.biocryst.com.

Argus Feb 17 session

+2.81% close to close Open Argus

Details

News Market Reaction – BCRX

On Feb 17, the day this news came out, BCRX closed 2.81% above the previous close.

Data tracked by StockTitan Argus for the Feb 17 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the T.D. Cowen 46^th Annual Health Care Conference in Boston on Tuesday, March 3, 2026, at 9:10 a.m. ET.

The link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
Investors:
investorrelations@biocryst.com

Media:
media@biocryst.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BioCryst (BCRX) present at the T.D. Cowen 46th Annual Health Care Conference?

BioCryst will present on Tuesday, March 3, 2026 at 9:10 a.m. ET. According to the company, the session is part of the conference's scheduled presentations in Boston and is open via the listed webcast link.

How can investors access the BioCryst (BCRX) live webcast for the March 3, 2026 presentation?

Investors can access the live audio webcast through BioCryst's investor website at www.biocryst.com. According to the company, the webcast link and a replay will be available in the Investors & Media section for later listening.

Will BioCryst (BCRX) provide a replay of its March 3, 2026 conference presentation?

Yes, a replay will be available via the company's investor site. According to the company, the audio replay will be posted in the Investors & Media section after the live presentation.

What topics will BioCryst (BCRX) cover during the March 3, 2026 T.D. Cowen presentation?

The announcement confirms BioCryst will present but does not list specific topics. According to the company, details beyond date, time, and webcast access were not provided in the event notice.